KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Alnylam Pharmaceuticals (ALNY) over the last 17 years, with Q4 2025 value amounting to $222.0 million.

  • Alnylam Pharmaceuticals' Change in Acquisitions & Divestments fell 4987.98% to $222.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.8 billion, marking a year-over-year increase of 1467.18%. This contributed to the annual value of $1.8 billion for FY2025, which is 1467.18% up from last year.
  • Alnylam Pharmaceuticals' Change in Acquisitions & Divestments amounted to $222.0 million in Q4 2025, which was down 4987.98% from $723.4 million recorded in Q3 2025.
  • In the past 5 years, Alnylam Pharmaceuticals' Change in Acquisitions & Divestments ranged from a high of $723.4 million in Q3 2025 and a low of $222.0 million during Q4 2025
  • For the 5-year period, Alnylam Pharmaceuticals' Change in Acquisitions & Divestments averaged around $431.1 million, with its median value being $409.8 million (2021).
  • As far as peak fluctuations go, Alnylam Pharmaceuticals' Change in Acquisitions & Divestments skyrocketed by 10748.67% in 2022, and later plummeted by 4987.98% in 2025.
  • Over the past 5 years, Alnylam Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $291.4 million in 2021, then soared by 107.49% to $604.7 million in 2022, then tumbled by 39.84% to $363.8 million in 2023, then grew by 21.77% to $443.0 million in 2024, then crashed by 49.88% to $222.0 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $222.0 million for Q4 2025, versus $723.4 million for Q3 2025 and $332.5 million for Q2 2025.